Judgment of the General Court of 6 April 2022 — Biogena v EUIPO — Alter Farmacia (NUTRIFEM AGNUBALANCE)

(Case T-370/21) (1)

(EU trade mark - Opposition proceedings - International registration designating the European Union - Word mark NUTRIFEM AGNUBALANCE - Earlier EU word mark NUTRIBEN - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)

(2022/C 222/46)

Language of the case: English

Parties

Applicant: Biogena GmbH & Co KG (Salzburg, Austria) (represented by: I. Schiffer, lawyer)

Defendant: European Union Intellectual Property Office (represented by: J.F. Crespo Carrillo, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO: Alter Farmacia, SA (Madrid, Spain)

Re:

Action brought against the decision of the Fifth Board of Appeal of EUIPO of 22 April 2021 (Case R 1208/2020-5), relating to opposition proceedings between Alter Farmacia and Biogena.

Operative part of the judgment

The Court:

1.

Annuls the decision of the Fifth Board of Appeal of EUIPO of 22 April 2021 (Case R 1208/2020-5) in so far as it concerns the goods in Class 5 of the Nice Agreement Concerning the International Classification of Goods and Services for the Purposes of the Registration of Marks of 15 June 1957, as revised and amended, and the ‘dried kitchen herbs; preserved herbs and spices’ in Class 30 thereof;

2.	Dismisses the action as to the remainder;

3.	Orders each party to bear its own costs.

---

(1)  OJ C 329, 16.8.2021.